ATE186121T1 - Verfahren zur bestimmung des präthrombotischen status - Google Patents

Verfahren zur bestimmung des präthrombotischen status

Info

Publication number
ATE186121T1
ATE186121T1 AT95942622T AT95942622T ATE186121T1 AT E186121 T1 ATE186121 T1 AT E186121T1 AT 95942622 T AT95942622 T AT 95942622T AT 95942622 T AT95942622 T AT 95942622T AT E186121 T1 ATE186121 T1 AT E186121T1
Authority
AT
Austria
Prior art keywords
determining
prethrombotic
status
amount
relates
Prior art date
Application number
AT95942622T
Other languages
English (en)
Inventor
Jean-Marie Freyssinet
Benedicte Antoni
Frederic Donie
Helmut Lill
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of ATE186121T1 publication Critical patent/ATE186121T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95942622T 1994-07-23 1995-07-19 Verfahren zur bestimmung des präthrombotischen status ATE186121T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94111514 1994-07-23

Publications (1)

Publication Number Publication Date
ATE186121T1 true ATE186121T1 (de) 1999-11-15

Family

ID=8216140

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95942622T ATE186121T1 (de) 1994-07-23 1995-07-19 Verfahren zur bestimmung des präthrombotischen status

Country Status (7)

Country Link
US (1) US7005271B1 (de)
EP (1) EP0772778B1 (de)
JP (1) JP3574659B2 (de)
AT (1) ATE186121T1 (de)
DE (1) DE69513027T2 (de)
ES (1) ES2139957T3 (de)
WO (1) WO1996003655A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284475B1 (en) * 1997-07-11 2001-09-04 Mount Sinai School Of Medicine Of The City Of New York Assays for diagnosis of thrombophilic disease
US7687272B1 (en) 1998-01-12 2010-03-30 Henry Buchwald Method and apparatus for determining blood oxygen transport
AU1218900A (en) * 1998-10-23 2000-05-15 Accumetrics, Inc. Method for determining platelet count
US6806091B1 (en) 1999-01-12 2004-10-19 Henry Buchwald Method and apparatus for determining blood oxygen transport
DE60138111D1 (de) * 2000-07-21 2009-05-07 Chemo Sero Therapeut Res Inst Verfahren zur reinigung eines kalziumionen-bindenden proteins
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7645739B2 (en) 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
EP1379266B1 (de) 2001-02-21 2007-04-18 SurroMed, Inc. Modifizierte annexin-proteine und verhinderung und behandlung von thrombose
US7635680B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US6746872B2 (en) * 2002-01-16 2004-06-08 Lifescan, Inc. Control compositions and methods of use for coagulation tests
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
ATE536889T1 (de) 2003-07-08 2011-12-15 Accumetrics Inc Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
WO2007086069A1 (en) * 2006-01-27 2007-08-02 Rappaport Family Institute For Research In The Medical Sciences Methods and kits for determining blood coagulation
FR2917172B1 (fr) * 2007-06-07 2014-01-03 Inst Nat Sante Rech Med Methode de mesure de l'activite plasmine des microparticules presentes dans un echantillon de fluide biologique et utilisation
US20100255514A1 (en) 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
JP5769417B2 (ja) 2007-08-16 2015-08-26 ザ ロイヤル インスティチューション フォー ザ アドバンスメント オブ ラーニング／マギル ユニバーシティ 腫瘍細胞由来微小胞
WO2012016216A2 (en) 2010-07-29 2012-02-02 Shire Human Genetic Therapies Assays for detection of glycosaminoglycans
US20150017672A1 (en) * 2012-02-01 2015-01-15 Shire Human Genetic Therapies Inc. Assays for detection of glycosaminoglycans

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668638A (en) 1983-03-24 1987-05-26 The Liposome Company, Inc. Liposome composition for lupus assay
FR2621128B1 (fr) 1987-09-30 1994-05-06 Sanofi Trousse et methode de dosage immunometrique applicables a des cellules entieres
US5340719A (en) 1990-11-23 1994-08-23 Corporation Coulter Method and apparatus for optically screening microscopic cells
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities
CA2072548A1 (en) 1992-06-26 1993-12-27 Michael W. Stewart Methods for determining antiphospholipid antibodies
DE4229933A1 (de) * 1992-09-08 1994-03-10 Max Planck Gesellschaft Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern
US5472852A (en) * 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients

Also Published As

Publication number Publication date
US7005271B1 (en) 2006-02-28
EP0772778A1 (de) 1997-05-14
WO1996003655A1 (en) 1996-02-08
DE69513027T2 (de) 2000-03-16
DE69513027D1 (de) 1999-12-02
ES2139957T3 (es) 2000-02-16
JPH10503023A (ja) 1998-03-17
EP0772778B1 (de) 1999-10-27
JP3574659B2 (ja) 2004-10-06

Similar Documents

Publication Publication Date Title
DE69513027D1 (de) Verfahren zur bestimmung des präthrombotischen status
TR199801390T2 (xx) Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler
DE69010893D1 (de) Verfahren zur behandlung von koks sowie löschen desselben.
FI843496A0 (fi) Anordning foer att finna tvaergaoende borrhaol i implantat i benmaergen.
DE69535448D1 (de) Vorrichtung zur Unterdrückung von stimulierter Brillouin Streuung
BG101717A (bg) Инхибитори на микрозомалния триглицерид пренасящ белтък и метод
DE69316948D1 (de) Lösliche Liganden für CD40
DE69711034D1 (de) Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen
DE60126795D1 (de) Verfahren und Kit zur Bestimmung der geographischen bzw. populationsmässigen Herkunft von Menschen
ATE268782T1 (de) Zusammensetzungen zur wundheilung
ATE255420T1 (de) Verwendung von tumorzellen zeitversetzt in kombination mit intakten antikörpern zur immunisierung
TR200000374T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavbeta6 antagonistleriyle tedavisi.
DE3486081D1 (de) Verfahren und testzusammensetzung zur bestimmung von wasserstoffperoxid.
DE69837015D1 (de) Verfahren zur Stabilisierung und Messung von Troponinkomplexen
DE69022425D1 (de) Verfahren zur Bestimmung der funktionellen Wirkung von freiem Protein S oder Protein C in einer Plasmaprobe.
IT8421788A0 (it) Composizione e metodo di pulitura.
DE69525226D1 (de) Vorrichtung und Verfahren zur Bestimmung von Wasserstoffperoxid
DE3586831D1 (de) Verfahren zur behandlung des bodens und zusammensetzung zur konservierung von stickstoff im boden.
DE69001248D1 (de) Verfahren und zusammensetzungen zur isolation von menschlichem relaxin.
DE3585238D1 (de) Verfahren zur bestimmung des reduzierten zustands von nicotinamid-adenin-dinukleotid.
DE3586371D1 (de) Verfahren zur behandlung des bodens und zusammensetzung zur konservierung von stickstoff im boden.
TR199801988T2 (xx) Kalp yetmezli�inin endotelin antagonistleri ile tedavisi i�in y�ntem.
DE59105482D1 (de) Verfahren und Mittel zur kolorimetrischen Bestimmung von Nitrationen.
IT8447751A0 (it) Composizione contenente polisaccaride per legare proteine specifiche, metodo per ottenerla e procedimento nonche' corredo di saggio che la impiegano
DE69627655D1 (de) Schneidelement, stopfen und verfahren zur verhinderung des eindringens von spül-schlamm in das schneidelement

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties